tetano
Editor, Senior Moderator
Eur Heart J Case Rep
. 2024 Jun 29;8(7):ytae308.
doi: 10.1093/ehjcr/ytae308. eCollection 2024 Jul. Case series: successful salvage from refractory cardiogenic shock caused by COVID-19-associated myocardial injury with temporary ventricular assist devices
Kohei Tonai[SUP] 1 [/SUP], Keiko Ohta-Ogo[SUP] 2 [/SUP], Satoshi Kainuma[SUP] 1 [/SUP], Naoki Tadokoro[SUP] 1 [/SUP], Yasumasa Tsukamoto[SUP] 3 [/SUP], Kinta Hatakeyama[SUP] 2 [/SUP], Tadaki Suzuki[SUP] 4 [/SUP], Satsuki Fukushima[SUP] 1 [/SUP]
Affiliations
Background: Coronavirus disease 2019 (COVID-19) is predominantly known to cause respiratory injury; however, the present case series highlights four instances in which the infection resulted in significant cardiac complications. Among such cases, some represent severe cardiogenic shock, which necessitates the immediate introduction of mechanical circulatory support (MCS) for salvage.
Case summary: This case series involved patients with COVID-19-associated myocardial injury leading to fulminant cardiogenic shock. These patients required immediate implementation of peripheral MCS, followed by an instant upgrade to a central MCS system due to anatomical limitations and severe biventricular dysfunction. Central MCS provided effective ventricular unloading, resulting in a significant and prompt improvement in ventricular function. The treatment timeline showed rapid deterioration followed by remarkable recovery within 2 weeks of MCS initiation, demonstrating the effectiveness of aggressive and tailored MCS strategies in managing severe COVID-19-related cardiac complications.
Discussion: This study provides significant insights into the cardiovascular implications of COVID-19, particularly in the context of severe myocardial injury that leads to cardiogenic shock. The report underscores the importance of early recognition and intervention in such cases, focusing on the use of MCS as a life-saving modality. The findings also revealed unique pathological features of COVID-19-associated myocardial injury, including macrophage-predominant infiltration and microthrombosis, which are distinct from the features of conventional myocarditis. These findings highlight the need for further research on the pathophysiology of COVID-19-related cardiac injuries and the development of targeted therapeutic strategies.
Keywords: Biventricular failure; COVID-19; Cardiogenic shock; Case series; Mechanical circulatory support; Ventricular assist device.
. 2024 Jun 29;8(7):ytae308.
doi: 10.1093/ehjcr/ytae308. eCollection 2024 Jul. Case series: successful salvage from refractory cardiogenic shock caused by COVID-19-associated myocardial injury with temporary ventricular assist devices
Kohei Tonai[SUP] 1 [/SUP], Keiko Ohta-Ogo[SUP] 2 [/SUP], Satoshi Kainuma[SUP] 1 [/SUP], Naoki Tadokoro[SUP] 1 [/SUP], Yasumasa Tsukamoto[SUP] 3 [/SUP], Kinta Hatakeyama[SUP] 2 [/SUP], Tadaki Suzuki[SUP] 4 [/SUP], Satsuki Fukushima[SUP] 1 [/SUP]
Affiliations
- PMID: 39035254
- PMCID: PMC11259187
- DOI: 10.1093/ehjcr/ytae308
Background: Coronavirus disease 2019 (COVID-19) is predominantly known to cause respiratory injury; however, the present case series highlights four instances in which the infection resulted in significant cardiac complications. Among such cases, some represent severe cardiogenic shock, which necessitates the immediate introduction of mechanical circulatory support (MCS) for salvage.
Case summary: This case series involved patients with COVID-19-associated myocardial injury leading to fulminant cardiogenic shock. These patients required immediate implementation of peripheral MCS, followed by an instant upgrade to a central MCS system due to anatomical limitations and severe biventricular dysfunction. Central MCS provided effective ventricular unloading, resulting in a significant and prompt improvement in ventricular function. The treatment timeline showed rapid deterioration followed by remarkable recovery within 2 weeks of MCS initiation, demonstrating the effectiveness of aggressive and tailored MCS strategies in managing severe COVID-19-related cardiac complications.
Discussion: This study provides significant insights into the cardiovascular implications of COVID-19, particularly in the context of severe myocardial injury that leads to cardiogenic shock. The report underscores the importance of early recognition and intervention in such cases, focusing on the use of MCS as a life-saving modality. The findings also revealed unique pathological features of COVID-19-associated myocardial injury, including macrophage-predominant infiltration and microthrombosis, which are distinct from the features of conventional myocarditis. These findings highlight the need for further research on the pathophysiology of COVID-19-related cardiac injuries and the development of targeted therapeutic strategies.
Keywords: Biventricular failure; COVID-19; Cardiogenic shock; Case series; Mechanical circulatory support; Ventricular assist device.